<DOC>
	<DOC>NCT00150384</DOC>
	<brief_summary>The purpose is to demonstrate the utility of Caduet (amlodipine/atorvastatin) in the African American population</brief_summary>
	<brief_title>Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Amlodipine, atorvastatin drug combination</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>African American men and women with concurrent hypertension and dyslipidemia that is either treated or untreated Subjects must satisfy the blood pressure and LDLC inclusion criteria for their respective Cardiovascular Risk group determined at screening Subjects currently being treated with concomitant amlodipine and atorvastatin therapy, including Caduet Subjects with blood pressure at goal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>